BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mathur P, Comstock E, McSweegan E, Mercer N, Kumar NS, Kottilil S. A pilot study to expand treatment of chronic hepatitis C in resource-limited settings. Antiviral Res 2017;146:184-90. [PMID: 28927676 DOI: 10.1016/j.antiviral.2017.09.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Catton M, Gray G, Griffin D, Hasegawa H, Kent SJ, Mackenzie J, McSweegan E, Mercer N, Wang L. 2017 international meeting of the Global Virus Network. Antiviral Res 2018;153:60-9. [PMID: 29421321 DOI: 10.1016/j.antiviral.2018.02.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Almeida EC, Gleriano JS, Pinto FKA, Coelho RA, Vivaldini SM, Gomes JNN, Santos AF, Sereno LS, Pereira GFM, Henriques SH, Chaves LDP. Access to viral hepatitis care: distribution of health services in the Northern region of Brazil. Rev Bras Epidemiol 2019;22Suppl 1:e190008. [PMID: 31576984 DOI: 10.1590/1980-549720190008.supl.1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Pozza R, McCoy-Hill C, Hall K, Hefner A, Wilgers K, Tapelband J, Masroor M, Hassanein T. Eradicating hepatitis C virus: The APRN's role. Nurse Pract 2019;44:16-27. [PMID: 31567700 DOI: 10.1097/01.NPR.0000586008.23422.2c] [Reference Citation Analysis]
4 Razavi H. Polaris Observatory—supporting informed decision-making at the national, regional, and global levels to eliminate viral hepatitis. Antiviral Therapy 2022;27:135965352210831. [DOI: 10.1177/13596535221083179] [Reference Citation Analysis]
5 Applegate TL, Fajardo E, Sacks JA. Hepatitis C Virus Diagnosis and the Holy Grail. Infectious Disease Clinics of North America 2018;32:425-45. [DOI: 10.1016/j.idc.2018.02.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
6 Taye BW. A Path to Ending Hepatitis C in Ethiopia: A Phased Public Health Approach to Achieve Micro-Elimination. Am J Trop Med Hyg 2019;101:963-72. [PMID: 31516107 DOI: 10.4269/ajtmh.19-0295] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Mathur P, Comstock E, Makuza JD, Emmanuel B, Sebeza J, Kiromera A, Wilson E, Kattakuzhy S, Nelson A, Kottilil S, Riedel DJ. Implementation of a unique hepatitis C care continuum model in Rwanda. J Public Health (Oxf) 2019;41:e203-8. [PMID: 29982813 DOI: 10.1093/pubmed/fdy115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]